Clinical Trial Update: The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the impact of ketamine on postoperative cognitive dysfunction, delirium, and renal dysfunction with completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Disorders
• Delirium
• Kidney Injury

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Mayo Clinic | Conditions: Cognitive Disorders, Delirium | Phase 2 | Status: COMPLETED | Results posted: 2022-02-15